Download PDF
Homeopathy 2018; 107(01): 010-018
DOI: 10.1055/s-0037-1621731
Review Article
The Faculty of Homeopathy

The N-of-1 Clinical Trial: A Timely Research Opportunity in Homeopathy

Susanne Ulbrich-Zürni
1   Swiss Homeopathy Association, Zürich, Switzerland
,
Michael Teut
2   Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany
,
Stephanie Roll
2   Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany
,
Robert T. Mathie
3   Homeopathy Research Institute, London, United Kingdom
› Author Affiliations Funding The study was supported by grants from the Swiss Homeopathy Association and the PanMedion Foundation, Switzerland.
Further Information

Publication History

03 May 2017

11 December 2017

Publication Date:
23 January 2018 (online)

   Permissions and Reprints

Abstract

Background The randomised controlled trial (RCT) is considered the ‘gold standard’ for establishing treatment efficacy or effectiveness of an intervention, but its data do not infer response in an individual patient. Individualised clinical care, a fundamental principle in complementary and alternative medicine (CAM), including homeopathy, seems well disposed in principle to being researched by single-patient (N-of-1) study design. Guidelines for reporting N-of-1 trials have recently been developed.

Objective To overview the current status in the literature of the N-of-1 method and its application in medicine, including CAM. To consider whether the N-of-1 trial design offers an opportunity for novel research in homeopathy.

N-of-1 Trial Design The N-of-1 trial applies the principles of the conventional crossover, blinded, RCT design. The treatment under study and the comparator are repeated in a randomised order, and with suitable washout time, over a defined period. N-of-1 design is constrained for use in chronic stable conditions, and for interventions that have quick onset and cessation of effect, with modest or negligible carryover. Outcome data can be aggregated and interpreted for the individual subject; they can also be pooled with data from several similar N-of-1 trials, enabling more generalisable conclusions.

The N-of-1 Trial in CAM The typical individualisation of patient care can be accommodated in N-of-1 study design if the patient and the specific therapeutic intervention are selected within the constraints of the method. Application of the N-of-1 method in CAM has been advocated but has been mainly limited, in practice, to a small number of studies in herbal and traditional Chinese medicine.

The N-of-1 Trial in Homeopathy Individualised homeopathy can be accommodated for investigation within the same methodological constraints; less in-depth homeopathic approaches to prescribing are also amendable to investigation using the N-of-1 method. No such studies have been published. We identify three main targets in its ready applicability to homeopathy: (1) to optimise clinical care in an individual patient; (2) to investigate whether the outcomes of treatment using homeopathy differ from those of placebo; (3) to aggregate data from a series of N-of-1 trials to enable broader conclusions about a group of patients or intervention.

Conclusion The N-of-1 trial design offers important new investigative possibilities in homeopathy and should be explored as a means to optimise individualised health care or investigate effectiveness of the homeopathic intervention compared with placebo in individual subjects.

Keywords

complementary and alternative medicine - homeopathy - N-of-1 trial - single-patient trial - research methods

Authors' Contributions

S.U.Z. and R.T.M. co-developed the original concept. S.U.Z. devised the manuscript and led its writing. Each author has provided edited content and has approved the final manuscript.


 

  • References

  • 1 Kleijnen J, Knipschild P, ter Riet G. Clinical trials of homoeopathy. BMJ 1991; 302: 316-323
    CrossrefPubMedGoogle Scholar
  • 2 Linde K, Clausius N, Ramirez G. , et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997; 350: 834-843
    CrossrefPubMedGoogle Scholar
  • 3 Linde K, Scholz M, Ramirez G, Clausius N, Melchart D, Jonas WB. Impact of study quality on outcome in placebo-controlled trials of homeopathy. J Clin Epidemiol 1999; 52: 631-636
    CrossrefPubMedGoogle Scholar
  • 4 Cucherat M, Haugh MC, Gooch M, Boissel JP. ; Homeopathic Medicines Research Advisory Group. Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. Eur J Clin Pharmacol 2000; 56: 27-33
    CrossrefPubMedGoogle Scholar
  • 5 Shang A, Huwiler-Müntener K, Nartey L. , et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005; 366: 726-732
    CrossrefPubMedGoogle Scholar
  • 6 Kravitz RL, Duan N, Vohra S, Li J. ; the DEcIDE Methods Center N-of-1 Guidance Panel. Introduction to N-of-1 trials: indications and barriers. In: Kravitz RL, Duan N. , eds. Design and Implementation of N-of-1 Trials: A User's Guide. AHRQ Publication No. 13(14)-EHC122-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2014: 1-12
    Google Scholar
  • 7 Guyatt G, Zhang Y, Jaeschke R, McGinn T. N-of-1 randomized clinical trials. In: Guyatt G, Rennie D, Meade MO, Cook DJ. , eds. User's Guide to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed. Chicago: McGraw-Hill Professional; 2015: 151-161
    Google Scholar
  • 8 Guyatt G, Sackett D, Adachi J. , et al. A clinician's guide for conducting randomized trials in individual patients. CMAJ 1988; 139: 497-503
    PubMedGoogle Scholar
  • 9 Vohra S, Shamseer L, Sampson M. , et al; CENT Group. CONSORT extension for reporting N-of-1 trials (CENT) 2015 statement. BMJ 2015; 350: h1738
    CrossrefPubMedGoogle Scholar
  • 10 Nikles J. What are N-of-1 trials?. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 9-18
    CrossrefGoogle Scholar
  • 11 Tate RL, McDonald S, Perdices M, Togher L, Schultz R, Savage S. Rating the methodological quality of single-subject designs and n-of-1 trials: introducing the Single-Case Experimental Design (SCED) Scale. Neuropsychol Rehabil 2008; 18: 385-401
    CrossrefPubMedGoogle Scholar
  • 12 Tate RL, Perdices M, Rosenkoetter U. , et al. Revision of a method quality rating scale for single-case experimental designs and n-of-1 trials: the 15-item risk of bias in N-of-1 Trials (RoBiNT) Scale. Neuropsychol Rehabil 2013; 23: 619-638
    CrossrefPubMedGoogle Scholar
  • 13 Carriere KC, Li Y, Mitchell G, Senior H. Methodological considerations of N-of-1 trials. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 67-80
    CrossrefGoogle Scholar
  • 14 Senior H. Randomization, allocation concealment, and blinding. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 81-92
    CrossrefGoogle Scholar
  • 15 Guyatt G, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S. Determining optimal therapy--randomized trials in individual patients. N Engl J Med 1986; 314: 889-892
    CrossrefPubMedGoogle Scholar
  • 16 Larson EB. N-of-1 clinical trials. A technique for improving medical therapeutics. West J Med 1990; 152: 52-56
    PubMedGoogle Scholar
  • 17 Kravitz RL, Duan N, Niedzinski EJ, Hay MC, Subramanian SK, Weisner TS. What ever happened to N-of-1 trials? Insiders' perspectives and a look to the future. Milbank Q 2008; 86: 533-555
    CrossrefPubMedGoogle Scholar
  • 18 Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ. The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?. Per Med 2011; 8: 161-173
    CrossrefPubMedGoogle Scholar
  • 19 Kravitz RL, Duan N. , eds. Design and Implementation of N-of-1 Trials: A User's Guide. AHRQ Publication No. 13(14)-EHC122-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2014
    Google Scholar
  • 20 Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015
    Google Scholar
  • 21 Shamseer L, Sampson M, Bukutu C. , et al; CENT Group. CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration. BMJ 2015; 350: h1793
    CrossrefPubMedGoogle Scholar
  • 22 Gabler NB, Duan N, Vohra S, Kravitz RL. N-of-1 trials in the medical literature: a systematic review. Med Care 2011; 49: 761-768
    CrossrefPubMedGoogle Scholar
  • 23 Punja S, Bukutu C, Shamseer L. , et al. Systematic review of the methods, statistical analysis and meta-analysis of N-of-1 trials. In: Punja S. , ed. N-of-1 Methods and their Contribution to Systematic Reviews and Meta-Analyses [thesis]. University of Alberta; 2014: 13-47
    Google Scholar
  • 24 Shaffer JA, Falzon L, Cheung K, Davidson KW. N-of-1 randomized trials for psychological and health behavior outcomes: a systematic review protocol. Syst Rev 2015; 4: 87
    CrossrefPubMedGoogle Scholar
  • 25 Li J, Gao W, Punja S. , et al. Reporting quality of N-of-1 trials published between 1985 and 2013: a systematic review. J Clin Epidemiol 2016; 76: 57-64
    CrossrefPubMedGoogle Scholar
  • 26 Nikles J. Where are N-of-1 trials headed?. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 233-242
    CrossrefGoogle Scholar
  • 27 Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Clin Epidemiol 2009; 62: 499-505
    CrossrefPubMedGoogle Scholar
  • 28 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Choice of Control Group in Clinical Trials 2000. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E10/Step4/E10_Guideline.pdf . Accessed December 3, 2016
    PubMedGoogle Scholar
  • 29 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Statistical Principles for Clinical Trials 1998. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf . Accessed December 3, 2016
    PubMedGoogle Scholar
  • 30 Schulz KF, Altman DG, Moher D. ; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg 2011; 9: 672-677
    CrossrefPubMedGoogle Scholar
  • 31 Guyatt G, Jaeschke R, Wilson MC, Montori VM, Richardson WS. What is evidence-based medicine?. In: Guyatt G, Rennie D, Meade MO, Cook DJ. , eds. User's Guide to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed. Chicago: McGraw-Hill Professional; 2015: 7-14
    Google Scholar
  • 32 Punja S, Schmid CH, Hartling L, Urichuk L, Nikles CJ, Vohra S. Amphetamine and methylphenidate for pediatric ADHD: a combined meta-analysis of N-of-1 trial data with RCT data. In: Punja S. , ed. N-of-1 Methods and Their Contribution to Systematic Reviews and Meta-Analyses [thesis]. University of Alberta; 2014: 197-212
    Google Scholar
  • 33 Punja S. N-of-1 Methods and Their Contribution to Systematic Reviews and Meta-Analyses [thesis]. University of Alberta; 2014
    PubMedGoogle Scholar
  • 34 Duan N, Kravitz RL, Schmid CH. Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research. J Clin Epidemiol 2013; 66: S21-S28
    CrossrefPubMedGoogle Scholar
  • 35 Schmid CH, Duan N. The DEcIDE Methods Center N-of-1 Guidance Panel. Statistical design and analytic considerations for N-of-1 trials. In: Kravitz RL, Duan N. , eds. Design and Implementation of N-of-1 Trials: A User's Guide. AHRQ Publication No. 13(14)-EHC122-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2014: 33-54
    Google Scholar
  • 36 Mitchell G. Aggregated N-of-1 trials. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 57-66
    CrossrefGoogle Scholar
  • 37 Zucker DR, Schmid CH, McIntosh MW, D'Agostino RB, Selker HP, Lau J. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J Clin Epidemiol 1997; 50: 401-410
    CrossrefPubMedGoogle Scholar
  • 38 Zucker DR, Ruthazer R, Schmid CH. Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. J Clin Epidemiol 2010; 63: 1312-1323
    CrossrefPubMedGoogle Scholar
  • 39 Nikles J, Mitchell GK, Schluter P. , et al. Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative care. J Clin Epidemiol 2011; 64: 471-480
    CrossrefPubMedGoogle Scholar
  • 40 Senior H. Data collection and quality control. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 93-104
    CrossrefGoogle Scholar
  • 41 Senior H. Assessing and reporting adverse events. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 115-124
    CrossrefGoogle Scholar
  • 42 Whitty JA, Byrnes JM, Scuffham PA. The economics of N-of-1 trials. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 155-174
    CrossrefGoogle Scholar
  • 43 Punja S, Vohra S, Eslick I, Duan N. ; the DEcIDE Methods Center N-of-1 Guidance Panel. An ethical framework for N-of-1 trials: Clinical care, quality improvement, or human subjects research?. In: Kravitz RL, Duan N. , eds. Design and Implementation of N-of-1 Trials: A User's Guide. AHRQ Publication No. 13(14)-EHC122-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2014: 13-22
    Google Scholar
  • 44 Crowden A, Guyatt G, Stepanov N, Vohra S. Research ethics and N-of-1 trials. In: Nikles J, Mitchell G. , eds. The Essential Guide to N-of-1 Trials in Health. Heidelberg: Springer; 2015: 125-134
    CrossrefGoogle Scholar
  • 45 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guideline for Good Clinical Practice 1996. Available at: http://www.ich.org/products/guidelines/efficacy/efficacy-single/article/good-clinical-practice.html . Accessed July 12, 2016
    PubMedGoogle Scholar
  • 46 Gaus W, Högel J. Studies on the efficacy of unconventional therapies. Problems and designs. Arzneimittelforschung 1995; 45: 88-92
    PubMedGoogle Scholar
  • 47 Hart A, Sutton CJ. n-of-1 trials and their combination: suitable approaches for CAM research?. Complement Ther Med 2003; 11: 213-214
    CrossrefPubMedGoogle Scholar
  • 48 Johnston BC, Mills E. N-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation. J Altern Complement Med 2004; 10: 979-984
    CrossrefPubMedGoogle Scholar
  • 49 Sung L, Feldman BM. N-of-1 trials: innovative methods to evaluate complementary and alternative medicines in pediatric cancer. J Pediatr Hematol Oncol 2006; 28: 263-266
    CrossrefPubMedGoogle Scholar
  • 50 Goldenberg JZ, Wenner CA. A novel N of 1 trial design and proposed utility in complementary and alternative medicine research. J Evid Based Complementary Altern Med 2012; 17: 126-130
    CrossrefPubMedGoogle Scholar
  • 51 Nahin RL, Straus SE. Research into complementary and alternative medicine: problems and potential. BMJ 2001; 322: 161-164
    CrossrefPubMedGoogle Scholar
  • 52 Coxeter PD, Schluter PJ, Eastwood HL, Nikles CJ, Glasziou PP. Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n-of-1 trials. Complement Ther Med 2003; 11: 215-222
    CrossrefPubMedGoogle Scholar
  • 53 Jackson A, MacPherson H, Hahn S. Acupuncture for tinnitus: a series of six n=1 controlled trials. Complement Ther Med 2006; 14: 39-46
    CrossrefPubMedGoogle Scholar
  • 54 Lee S, Lim N, Choi SM, Kim S. Validation study of Kim's sham needle by measuring facial temperature: an N-of-1 randomized double-blind placebo-controlled clinical trial. Evid Based Complement Alternat Med 2012; DOI: 10.1155/2012/507937.
    CrossrefPubMedGoogle Scholar
  • 55 Yuhong H, Qian L, Yu L. , et al. An N-of-1 trial service in clinical practice: testing the effectiveness of Liuwei Dihuang decoction for kidney-Yin deficiency syndrome. Evid Based Complement Alternat Med 2013; DOI: 10.1155/2013/827915.
    CrossrefPubMedGoogle Scholar
  • 56 Huang H, Yang P, Xue J. , et al. Evaluating the individualized treatment of traditional Chinese medicine: a pilot study of N-of-1 trials. Evid Based Complement Alternat Med 2014; DOI: 10.1155/2014/148730.
    CrossrefPubMedGoogle Scholar
  • 57 Li J, Tian J, Ma B, Yang K. N-of-1 trials in China. Complement Ther Med 2013; 21: 190-194
    CrossrefPubMedGoogle Scholar
  • 58 Kawakita K, Suzuki M, Namura K, Tanzawa S. A proposal for a simple and useful research design for evaluating the efficacy of acupuncture: multiple, randomized n-of-1 trials. Japanese Acupuncture and Moxibustion 2005; 1: 9-15
    PubMedGoogle Scholar
  • 59 Kawakita K, Shichidou T, Inoue E. , et al. Do Japanese style acupuncture and moxibustion reduce symptoms of the common cold?. Evid Based Complement Alternat Med 2008; 5: 481-489
    CrossrefPubMedGoogle Scholar
  • 60 Witt C, Linde K. Clinical Research in Complementary and Integrative Medicine: A Practical Training Book. Munich: Urban & Fischer Verlag/Elsevier GmbH; 2011
    Google Scholar
  • 61 Teut M, Linde K. Scientific case research in complementary and alternative medicine–a review. Complement Ther Med 2013; 21: 388-395
    CrossrefPubMedGoogle Scholar
  • 62 Dahler J. Potenzen und ihre k Dosierung. In: Teut M, Dahler J, Lucae C. , et al, eds. Kursbuch Homöopathie. 2nd ed. München: Urban & Fischer Verlag/Elsevier GmbH; 2016: 135-148
    Google Scholar
  • 63 Hahnemann S. Organon der Heilkunst. Originalgetreuer Nachdruck der sechsten Auflage von 1921. Kandern, Germany: Narayana-Verlag; 2011
    Google Scholar
  • 64 Ludtke R, Wiesenauer M. A meta-analysis of the homeopathic treatment of pollinosis with Galphimia glauca. Forsch Komplementarmed 1996; 3: 230-236
    PubMedGoogle Scholar
  • 65 Cooper KL, Relton C. Homeopathy for insomnia: a systematic review of research evidence. Sleep Med Rev 2010; 14: 329-337
    CrossrefPubMedGoogle Scholar
  • 66 Ernst E. Homeopathy for insomnia and sleep-related disorders: a systematic review of randomised controlled trials. Focus Altern Complement Ther 2011; 16: 195-199
    CrossrefPubMedGoogle Scholar
  • 67 Long L, Ernst E. Homeopathic remedies for the treatment of osteoarthritis: a systematic review. Br Homeopath J 2001; 90: 37-43
    Article in Thieme ConnectPubMedGoogle Scholar
  • 68 Taylor MA, Reilly D, Llewellyn-Jones RH, McSharry C, Aitchison TC. Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. BMJ 2000; 321: 471-476
    CrossrefPubMedGoogle Scholar
  • 69 Ernst E. Homeopathic Galphimia glauca for hay fever: a systematic review of randomised clinical trials and a critique of a published meta-analysis. Focus Altern Complement Ther 2011; 16: 200-203
    CrossrefPubMedGoogle Scholar
  • 70 Ernst E. Homeopathic prophylaxis of headaches and migraine? A systematic review. J Pain Symptom Manage 1999; 18: 353-357
    CrossrefPubMedGoogle Scholar
  • 71 Yakir M, Kreitler S, Brzezinski A, Vithoulkas G, Oberbaum M, Bentwich Z. Effects of homeopathic treatment in women with premenstrual syndrome: a pilot study. Br Homeopath J 2001; 90: 148-153
    Article in Thieme ConnectPubMedGoogle Scholar
  • 72 Mathie RT, Lloyd SM, Legg LA. , et al. Randomised placebo-controlled trials of individualised homeopathic treatment: systematic review and meta-analysis. Syst Rev 2014; 3: 142
    CrossrefPubMedGoogle Scholar
  • 73 Katz T, Fisher P, Katz A, Davidson J, Feder G. The feasibility of a randomised, placebo-controlled clinical trial of homeopathic treatment of depression in general practice. Homeopathy 2005; 94: 145-152
    Article in Thieme ConnectPubMedGoogle Scholar
  • 74 Adler UC, Krüger S, Teut M. , et al. Homeopathy for depression: a randomized, partially double-blind, placebo-controlled, four-armed study (DEP-HOM). PLoS One 2013; 8: e74537
    CrossrefPubMedGoogle Scholar
  • 75 Bell IR. Depression research in homeopathy: hopeless or hopeful?. Homeopathy 2005; 94: 141-144
    Article in Thieme ConnectPubMedGoogle Scholar